Wuhu Token Sciences Co., Ltd. (SHE:300088)
China · Delayed Price · Currency is CNY 7.27
+0.03 (0.41%)
May 8, 2026, 3:12 PM CST
Wuhu Token Sciences Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 11,131 | 11,460 | 11,020 | 8,770 | 6,911 | 6,956 |
Other Revenue | 112.81 | 112.81 | 37.54 | 118.78 | 76.32 | 62.71 |
| 11,244 | 11,573 | 11,058 | 8,889 | 6,987 | 7,018 | |
Revenue Growth (YoY) | -0.04% | 4.66% | 24.40% | 27.21% | -0.44% | 2.55% |
Cost of Revenue | 10,137 | 10,429 | 10,075 | 8,047 | 5,696 | 5,380 |
Gross Profit | 1,107 | 1,144 | 982.31 | 842.05 | 1,291 | 1,638 |
Selling, General & Admin | 381.47 | 368.28 | 341.39 | 289.52 | 317.5 | 284.69 |
Research & Development | 449.77 | 465.36 | 428.59 | 334.14 | 330.02 | 301.59 |
Other Operating Expenses | -81.71 | -59.77 | -37.14 | -18.48 | 44.86 | 34.05 |
Operating Expenses | 746.12 | 773.58 | 661.12 | 636.76 | 694.9 | 643.75 |
Operating Income | 361.26 | 370.58 | 321.2 | 205.29 | 595.9 | 994.3 |
Interest Expense | -78.61 | -79.31 | -73.41 | -45.02 | -22.97 | -28.74 |
Interest & Investment Income | 71.83 | 72.7 | 59.27 | 49.12 | 21.22 | 45.48 |
Currency Exchange Gain (Loss) | -21.02 | -21.02 | 30.87 | 34.16 | 106.48 | -31.51 |
Other Non Operating Income (Expenses) | -52.9 | -20.33 | -4.03 | -0.72 | -2.29 | 6.05 |
EBT Excluding Unusual Items | 280.56 | 322.62 | 333.9 | 242.82 | 698.34 | 985.6 |
Impairment of Goodwill | - | - | - | -16.79 | - | -11.33 |
Gain (Loss) on Sale of Investments | -88.1 | -87.24 | 0.17 | -51.92 | -23.79 | -0.02 |
Gain (Loss) on Sale of Assets | 1.89 | 0.01 | 6.59 | 54.13 | -10.93 | -1.61 |
Asset Writedown | 2.48 | -1.79 | -1.13 | -0.4 | -10.66 | -0.08 |
Other Unusual Items | 10.45 | 10.45 | 20.98 | 88.55 | 76.65 | 87.19 |
Pretax Income | 207.27 | 244.04 | 360.51 | 316.4 | 729.6 | 1,060 |
Income Tax Expense | -1.14 | 3.39 | -6.29 | 20.72 | 17.21 | 126.82 |
Earnings From Continuing Operations | 208.41 | 240.65 | 366.8 | 295.68 | 712.39 | 932.93 |
Minority Interest in Earnings | -36.6 | -37.05 | -10.01 | -54.11 | -32.73 | -28.69 |
Net Income | 171.81 | 203.6 | 356.79 | 241.56 | 679.66 | 904.24 |
Net Income to Common | 171.81 | 203.6 | 356.79 | 241.56 | 679.66 | 904.24 |
Net Income Growth | -55.61% | -42.94% | 47.70% | -64.46% | -24.84% | 8.39% |
Shares Outstanding (Basic) | 2,551 | 2,545 | 2,379 | 2,416 | 2,427 | 2,444 |
Shares Outstanding (Diluted) | 2,551 | 2,545 | 2,379 | 2,416 | 2,427 | 2,512 |
Shares Change (YoY) | 7.11% | 6.99% | -1.53% | -0.48% | -3.36% | 2.37% |
EPS (Basic) | 0.07 | 0.08 | 0.15 | 0.10 | 0.28 | 0.37 |
EPS (Diluted) | 0.07 | 0.08 | 0.15 | 0.10 | 0.28 | 0.36 |
EPS Growth | -58.55% | -46.67% | 50.00% | -64.29% | -22.22% | 5.88% |
Free Cash Flow | -6.56 | 35.25 | -750.44 | -638.05 | 369.86 | -186.68 |
Free Cash Flow Per Share | -0.00 | 0.01 | -0.32 | -0.26 | 0.15 | -0.07 |
Dividend Per Share | 0.050 | 0.050 | 0.060 | 0.070 | 0.100 | 0.050 |
Dividend Growth | -16.67% | -16.67% | -14.29% | -30.00% | 100.00% | -50.00% |
Gross Margin | 9.85% | 9.89% | 8.88% | 9.47% | 18.47% | 23.34% |
Operating Margin | 3.21% | 3.20% | 2.90% | 2.31% | 8.53% | 14.17% |
Profit Margin | 1.53% | 1.76% | 3.23% | 2.72% | 9.73% | 12.88% |
Free Cash Flow Margin | -0.06% | 0.30% | -6.79% | -7.18% | 5.29% | -2.66% |
EBITDA | 1,050 | 1,066 | 1,045 | 1,014 | 1,261 | 1,585 |
EBITDA Margin | 9.34% | 9.21% | 9.45% | 11.41% | 18.05% | 22.59% |
D&A For EBITDA | 688.5 | 695.58 | 723.9 | 808.72 | 665.2 | 591.11 |
EBIT | 361.26 | 370.58 | 321.2 | 205.29 | 595.9 | 994.3 |
EBIT Margin | 3.21% | 3.20% | 2.90% | 2.31% | 8.53% | 14.17% |
Effective Tax Rate | - | 1.39% | - | 6.55% | 2.36% | 11.97% |
Revenue as Reported | 11,244 | 11,573 | 11,058 | 8,889 | 6,987 | 7,018 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.